Association of angiotensin II blockers with survival among men with prostate cancer: Results from CaPSURE.

4538 Background: Pre-clinical data suggests that angiotensin II blockade can modulate androgen receptor expression in prostate cell lines leading to inhibition of cell growth, but clinical data to ...